Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022

Cèlia Ventura-Gabarró; Vivian H. Leung; Vera Vlahović-Palčevski; Anna Machowska; Dominique L. Monnet; Liselotte Diaz Högberg; ESAC-Net study group; Ieva Rutkovska

doi:10.2807/1560-7917.ES.2023.28.46.2300604

Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022

Cèlia Ventura-Gabarró (Corresponding Author)
, Vivian H. Leung
, Vera Vlahović-Palčevski
, Anna Machowska
, Dominique L. Monnet
, Liselotte Diaz Högberg
, ESAC-Net study group
, Ieva Rutkovska (Member of the Working Group)

Research output: Contribution to journal › Article › peer-review

22 Citations (Scopus)

Abstract

We observed a rebound in consumption of antibacterials for systemic use (ATC J01) in the community sector in the European Union/European Economic Area during 2021 and 2022, after an observed decrease between 2019 and 2020. The rates in 2022 returned to preCOVID-19-pandemic levels and were exceeded in 13 countries. Although these patterns could partly be a result of changes in disease transmission during the study period, it could also reflect a lost opportunity to strengthen and reinforce prudent antibiotic use.

Original language	English
Article number	2300604
Number of pages	5
Journal	EUROSURVEILLANCE
Volume	28
Issue number	46
DOIs	https://doi.org/10.2807/1560-7917.ES.2023.28.46.2300604
Publication status	Published - 16 Nov 2023
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Field of Science*

3.1 Basic medicine
3.3 Health sciences

Publication Type*

1.1. Scientific article indexed in Web of Science and/or Scopus database

Access to Document

10.2807/1560-7917.ES.2023.28.46.2300604

Cite this

@article{0f54bab29d1f46a599a5320ca2737055,

title = "Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022",

abstract = "We observed a rebound in consumption of antibacterials for systemic use (ATC J01) in the community sector in the European Union/European Economic Area during 2021 and 2022, after an observed decrease between 2019 and 2020. The rates in 2022 returned to preCOVID-19-pandemic levels and were exceeded in 13 countries. Although these patterns could partly be a result of changes in disease transmission during the study period, it could also reflect a lost opportunity to strengthen and reinforce prudent antibiotic use.",

author = "C{\`e}lia Ventura-Gabarr{\'o} and Leung, \{Vivian H.\} and Vera Vlahovi{\'c}-Pal{\v c}evski and Anna Machowska and Monnet, \{Dominique L.\} and H{\"o}gberg, \{Liselotte Diaz\} and \{ESAC-Net study group\} and Reinhild Strauss and Lucy Catteau and Ivan Stoikov and Marina Payerl-Pal and Isavella Kyriakidou and Michal Proke{\v s} and Majda Attauabi and Janne Sepp and Emmi Sarvikivi and Karima Hider-Mlynarz and Birgitta Schweickert and Kassiani Mellou and Maria Matuz and Halld{\'o}rsd{\'o}ttir, \{Anna Margr{\'e}t\} and Gurpinar, \{Emre Umut\} and Filomena Fortinguerra and Ieva Rutkovska and Rolanda Valinteliene and St{\'e}phanie Saleh and Peter Zarb and Jan Baltink and Blix, \{Hege Salvesen\} and Anna Olcza-Pie{\'n}kowska and Ana Silva and Popescu, \{Gabriel Adrian\} and Tom{\'a}{\v s} Tesa{\v r} and Maja Subelj and Antonio L{\'o}pez-Navas and Ragda Obeid",

note = "List of national organisations participating in ESAC-Net: https://www.ecdc.europa.eu/en/about-us/partnerships-and-networks/disease-and-laboratory-networks/esac-net Publisher Copyright: {\textcopyright} 2023 European Centre for Disease Prevention and Control (ECDC). All rights reserved.",

year = "2023",

month = nov,

day = "16",

doi = "10.2807/1560-7917.ES.2023.28.46.2300604",

language = "English",

volume = "28",

journal = "EUROSURVEILLANCE",

issn = "1025-496X",

publisher = "European Centre for Disease Prevention and Control (ECDC)",

number = "46",

}

TY - JOUR

T1 - Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022

AU - Ventura-Gabarró, Cèlia

AU - Leung, Vivian H.

AU - Vlahović-Palčevski, Vera

AU - Machowska, Anna

AU - Monnet, Dominique L.

AU - Högberg, Liselotte Diaz

AU - ESAC-Net study group

A2 - Strauss, Reinhild

A2 - Catteau, Lucy

A2 - Stoikov, Ivan

A2 - Payerl-Pal, Marina

A2 - Kyriakidou, Isavella

A2 - Prokeš, Michal

A2 - Attauabi, Majda

A2 - Sepp, Janne

A2 - Sarvikivi, Emmi

A2 - Hider-Mlynarz, Karima

A2 - Schweickert, Birgitta

A2 - Mellou, Kassiani

A2 - Matuz, Maria

A2 - Halldórsdóttir, Anna Margrét

A2 - Gurpinar, Emre Umut

A2 - Fortinguerra, Filomena

A2 - Rutkovska, Ieva

A2 - Valinteliene, Rolanda

A2 - Saleh, Stéphanie

A2 - Zarb, Peter

A2 - Baltink, Jan

A2 - Blix, Hege Salvesen

A2 - Olcza-Pieńkowska, Anna

A2 - Silva, Ana

A2 - Popescu, Gabriel Adrian

A2 - Tesař, Tomáš

A2 - Subelj, Maja

A2 - López-Navas, Antonio

A2 - Obeid, Ragda

N1 - List of national organisations participating in ESAC-Net: https://www.ecdc.europa.eu/en/about-us/partnerships-and-networks/disease-and-laboratory-networks/esac-net Publisher Copyright: © 2023 European Centre for Disease Prevention and Control (ECDC). All rights reserved.

PY - 2023/11/16

Y1 - 2023/11/16

N2 - We observed a rebound in consumption of antibacterials for systemic use (ATC J01) in the community sector in the European Union/European Economic Area during 2021 and 2022, after an observed decrease between 2019 and 2020. The rates in 2022 returned to preCOVID-19-pandemic levels and were exceeded in 13 countries. Although these patterns could partly be a result of changes in disease transmission during the study period, it could also reflect a lost opportunity to strengthen and reinforce prudent antibiotic use.

AB - We observed a rebound in consumption of antibacterials for systemic use (ATC J01) in the community sector in the European Union/European Economic Area during 2021 and 2022, after an observed decrease between 2019 and 2020. The rates in 2022 returned to preCOVID-19-pandemic levels and were exceeded in 13 countries. Although these patterns could partly be a result of changes in disease transmission during the study period, it could also reflect a lost opportunity to strengthen and reinforce prudent antibiotic use.

UR - https://www.scopus.com/pages/publications/85177977375

U2 - 10.2807/1560-7917.ES.2023.28.46.2300604

DO - 10.2807/1560-7917.ES.2023.28.46.2300604

M3 - Article

C2 - 37971660

AN - SCOPUS:85177977375

SN - 1025-496X

VL - 28

JO - EUROSURVEILLANCE

JF - EUROSURVEILLANCE

IS - 46

M1 - 2300604

ER -

Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022

Abstract

UN SDGs

Field of Science*

Publication Type*

Access to Document

Other files and links

Fingerprint

Cite this